IL6 and cardiomyopathy: LLLT can suppress circulating cytokines levels, in particular, tumor necrosis factor-α (TNF-α) and interleukin (IL)-6, these cytokines can promote progressive left ventricular (LV) dysfunction, LV remodeling, and cardiomyopathy [19].